Nutrien Stock Price, Forecast & Analysis (NYSE:NTR)

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien announced a quarterly dividend on Tuesday, July 30th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.45 per share on Thursday, October 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 3.71%. The ex-dividend date is Friday, September 27th. This is an increase from Nutrien's previous quarterly dividend of $0.43. View Nutrien's Dividend History.

Nutrien Ltd (NYSE:NTR) released its earnings results on Monday, November, 4th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.36 by $0.12. The business had revenue of $4.13 billion for the quarter, compared to analysts' expectations of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. The firm's revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.47 EPS. View Nutrien's Earnings History.

Nutrien is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Nutrien.

15 Wall Street analysts have issued 1-year price targets for Nutrien's stock. Their forecasts range from $50.00 to $70.00. On average, they expect Nutrien's stock price to reach $61.00 in the next twelve months. This suggests a possible upside of 25.6% from the stock's current price. View Analyst Price Targets for Nutrien.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 4 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nutrien.

Media stories about NTR stock have trended very negative on Tuesday, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nutrien earned a news impact score of -3.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Nutrien.

Nutrien saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 4,980,000 shares, an increase of 6.0% from the August 30th total of 4,700,000 shares. Based on an average trading volume of 1,350,000 shares, the short-interest ratio is presently 3.7 days. Approximately 0.9% of the shares of the company are short sold. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Mosaic (MOS), Israel Chemicals (ICL), Scotts Miracle-Gro (SMG), Nufarm (NUF), American Vanguard (AVD), CVR Partners (UAN), Marrone Bio Innovations (MBII), Calyxt (CLXT), Wynnstay Group (WYN), Evogene (EVGN), Arcadia Biosciences (RKDA), SenesTech (SNES), China Green Agriculture (CGA) and Eden Research (EDEN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Cimarex Energy (XEC), General Electric (GE), JPMorgan Chase & Co. (JPM), Micron Technology (MU), Verizon Communications (VZ), CVS Health (CVS), Cisco Systems (CSCO), Wells Fargo & Co (WFC) and Intel (INTC).

Nutrien's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Beutel Goodman & Co Ltd. (2.30%), CIBC Asset Management Inc (1.25%), Great West Life Assurance Co. Can (0.96%), Cambiar Investors LLC (0.48%), Sumitomo Mitsui Trust Holdings Inc. (0.43%) and Letko Brosseau & Associates Inc. (0.25%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Beutel Goodman & Co Ltd., Addenda Capital Inc., CWM LLC, QV Investors Inc., Russell Investments Group Ltd., Tocqueville Asset Management L.P. and Sumitomo Mitsui Trust Holdings Inc..

NTR stock was bought by a variety of institutional investors in the last quarter, including TIAA FSB, Great West Life Assurance Co. Can, Alberta Investment Management Corp, Zurcher Kantonalbank Zurich Cantonalbank, Massachusetts Financial Services Co. MA, ARGA Investment Management LP, Tower Research Capital LLC TRC and BBVA USA Bancshares Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $48.57.

Nutrien has a market capitalization of $27.83 billion and generates $19.64 billion in revenue each year. The company earns $3.57 billion in net income (profit) each year or $2.69 on an earnings per share basis. Nutrien employs 20,300 workers across the globe.View Additional Information About Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]